| Home > Publications database > ACSL4-associated lipid metabolism is a distinct therapeutic vulnerability in KMT2A-rearranged acute myeloid leukemia. > Access to Fulltext |
1-s2.0-S2211124726000884-main
|
|||||||
| version 1 |
| ||||||